RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.
•Tumors “educate” platelets (TEPs) by altering the platelet RNA profile
•TEPs provide a RNA biosource for pan-cancer, multiclass, and companion diagnostics
•TEP-based liquid biopsies may guide clinical diagnostics and therapy selection
•A total of 100–500 pg of total platelet RNA is sufficient for TEP-based diagnostics
Tumor-educated blood platelets (TEPs) are implicated as central players in the systemic and local responses to tumor growth, thereby altering their RNA profile. We determined the diagnostic potential of TEPs by mRNA sequencing of 283 platelet samples. We distinguished 228 patients with localized and metastasized tumors from 55 healthy individuals with 96% accuracy. Across six different tumor types, the location of the primary tumor was correctly identified with 71% accuracy. Also, MET or HER2-positive, and mutant KRAS, EGFR, or PIK3CA tumors were accurately distinguished using surrogate TEP mRNA profiles. Our results indicate that blood platelets provide a valuable platform for pan-cancer, multiclass cancer, and companion diagnostics, possibly enabling clinical advances in blood-based “liquid biopsies”.
| ||0 Комментариев · 3614 Прочтений - |